Journal Home
Search for

Volume 87, Issue 1, Pages 51-56 (January 2010)


View previous. 11 of 25 View next.

Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction

U. Görmüşa, D. ÖzmenbCorresponding Author Informationemail address, B. Özmenc, Z. Parıldarb, Ö. Özdoğand, I. Mutafb, O. Bayındırb

Received 25 May 2009; received in revised form 6 October 2009; accepted 19 October 2009. published online 23 November 2009.

Abstract 

Aims

: The aim of this study was to determine serum NT-proBNP and plasma Hcy levels and to explore the relationship between serum NT-proBNP and plasma Hcy levels in type 2 diabetic patients with and without asymptomatic LVDD.

Methods

: NT-proBNP and Hcy levels were measured 31 patients with type 2 diabetes mellitus. According to echocardiographic data, diabetic patients were divided into two groups: normal LV function or LV diastolic dysfunction.

Results

: Serum NT-proBNP levels in diabetic patients with LVDD were significantly higher than in diabetic patients with normal LV function and controls. The area under the receiver-operating characteristic (ROC) curve for NT-proBNP to separate normal vs. diastolic dysfunction was 0.96 in type 2 diabetic patients. Plasma Hcy levels were significantly higher in both diabetic groups than in controls. Positive correlation was noted between NT-proBNP and Hcy levels in diabetic patients with LVDD (r=0.881, p=0.0001).

Conclusions

: The correlation between elevated NT-proBNP and Hcy levels in diabetic patients with LVDD suggest an association between homocysteinemia and increased NT-proBNP secretion. Our data indicate that NT-proBNP may be a simple screening tool to select diabetic patients with LVDD requiring further examination with echocardiography.

a Department of Molecular Medicine, Institute of Experimental Medical Research, İstanbul University, İstanbul, Turkey

b Department of Clinical Biochemistry, Ege University School of Medicine, İzmir 35100, Turkey

c Department of Endocrinology, Celal Bayar University School of Medicine, Manisa 45100, Turkey

d Department of Cardiology, Ege University School of Medicine, İzmir 35100, Turkey

Corresponding Author InformationCorresponding author. Tel.: +90 232 3903378; fax: +90 232 3392144.

PII: S0168-8227(09)00435-5

doi:10.1016/j.diabres.2009.10.010


View previous. 11 of 25 View next.